Concepedia

Shiloh M. Martin

SM

Statistics

Publications

6

Citations

132

H-Index

6

Active since

2001

Affiliations

University of California, Davis(Current)

University of California Davis Medical Center

University of North Carolina at Chapel Hill

VA Northern California Health Care System

Shiloh M. Martin is an author at University of California, Davis specializing in pathology, medicine, and immunology.

Top concepts

Publications per year

2001–2011

6

Publications

6

Efficacy, Biodistribution, and Pharmacokinetics of CD22-Targeted Pegylated Liposomal Doxorubicin in a B-cell Non–Hodgkin's Lymphoma Xenograft Mouse Model

Joseph M. Tuscano, Shiloh M. Martin, Yunpeng Ma et al. · Clinical Cancer Research · 2010 · 54 citations

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)

Robert T. OʼDonnell, Shiloh M. Martin, Yunpeng Ma et al. · Investigational New Drugs · 2009 · 23 citations · Full text

The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone

Joseph M. Tuscano, Yunpeng Ma, Shiloh M. Martin et al. · Cancer Immunology Immunotherapy · 2011 · 16 citations · Full text

, , +22

Imaging and Pharmacokinetics of 64Cu-DOTA-HB22.7 Administered by Intravenous, Intraperitoneal, or Subcutaneous Injection to Mice Bearing Non-Hodgkin’s Lymphoma Xenografts

Shiloh M. Martin, Robert T. OʼDonnell, David L. Kukis et al. · Molecular Imaging and Biology · 2008 · 16 citations

, , +9

The Bispecific Anti-CD20/CD22 Antibody (Bs20x22) Has More Lymphomacidal Activity Than the Parent Antibodies Both Alone or In Combination

Laura F. Newell, Joseph M. Tuscano, Yunpeng Ma et al. · Blood · 2010 · 12 citations

1–5 of 6